[at noodls] – Conference Call Scheduled for March 8, 2013 at 8:30 a.m. ET ALBANY, N.Y., March 7, 2013 (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboardSee who AngioDynamics is hiring next, click here to view […]
[at noodls] – ALBANY, N.Y., Feb. 13, 2013 (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboardSee who AngioDynamics is hiring next, click here to view […]
[at noodls] – ALBANY, N.Y., Feb. 1, 2013 (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboardSee who AngioDynamics is hiring next, click here to view […]
[at noodls] – ALBANY, N.Y., Jan. 23, 2013 (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboardSee who AngioDynamics is hiring next, click here to view […]
[at noodls] – ALBANY, N.Y., Jan. 15, 2013 (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboardSee who AngioDynamics is hiring next, click here to view […]
[at noodls] – Pro forma net sales growth of 3% to $87 million Adjusted (Non-GAAP) Net Income of $0.10 per share; GAAP Net Income of $0.06 per share Adjusted EBITDA of $13.8 million; or $0.39 per share, a 26% YOY increase … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboardSee who […]
[at noodls] – ALBANY, N.Y., Jan. 3, 2013 (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboardSee who AngioDynamics is hiring next, click here to view […]
[at noodls] – ALBANY, N.Y., Dec. 19, 2012 (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboardSee who AngioDynamics is hiring next, click here to view […]
[at noodls] – ALBANY, N.Y., Dec. 17, 2012 (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboardSee who AngioDynamics is hiring next, click here to view […]
[at noodls] – ALBANY, N.Y., Nov. 19, 2012 (GLOBE NEWSWIRE) — AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease … moreView todays social media effects on ANGOView the latest stocks trending across Twitter. Click to view dashboard […]
